Diabetes mellitus and inflammation (Q38089671)

28 August 2017

Diabetes mellitus and inflammation (English)

1 reference

28 August 2017

2

Eugene Sobngwi

1 reference

28 August 2017

4

Andre Pascal Kengne

1 reference

28 August 2017

Eric Lontchi-Yimagou

1

1 reference

PubMed ID

23494755

28 August 2017

Tandi E Matsha

series ordinal

3

1 reference

28 August 2017

1 June 2013

1 reference

28 August 2017

Current diabetes report

1 reference

28 August 2017

13

1 reference

28 August 2017

435-444

1 reference

28 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-013-0375-y

28 August 2017

0 references

cites work

Inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Inflammation and type one diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Aspirin and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Therapeutic approaches to target inflammation in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Obesity, Inflammation, and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Adaptive immunity in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

State of the union between metabolism and the immune system in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Islet inflammation in type 2 diabetes: from metabolic stress to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Neuroinflammation in overnutrition-induced diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Hypoxia and adipose tissue function and dysfunction in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Hypoxia in obesity - from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

High-fat diet induces periodontitis in mice through lipopolysaccharides (LPS) receptor signaling: protective action of estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Individual saturated fatty acids are associated with different components of insulin resistance and glucose metabolism: the GOCADAN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Diabetes mellitus and periodontitis: a tale of two common interrelated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Periodontitis and insulin resistance: casual or causal relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Interactions between the microbiota and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Immuno-microbiota cross and talk: the new paradigm of metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Air pollution and type 2 diabetes: mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Diabetes incidence and long-term exposure to air pollution: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Epidemiological and experimental links between air pollution and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Vitamin D and type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Focus on vitamin D, inflammation and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

The vagus nerve and the inflammatory reflex--linking immunity and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

The true cost of in-patient obesity: impact of obesity on inflammatory stress and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

The linkage between inflammation and Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

The role of epigenetics in the pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Leptin, from fat to inflammation: old questions and new insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Leptin and mTOR: partners in metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

The weight of leptin in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg Study 1984-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Chemerin: a potential endocrine link between obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Towards an integrative approach to understanding the role of chemerin in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Regulation of adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

The role of TNFalpha and TNF receptors in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Inflammation during obesity is not all bad: evidence from animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Obesity, inflammation, and insulin resistance--a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Origin and physiological roles of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

SOCS proteins causing trouble in insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Molecular targets related to inflammation and insulin resistance and potential interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Potential role of salicylates in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Effects of etanercept in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Systematic Review: Vitamin D and Cardiometabolic Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

New hope for type 2 diabetics: targeting insulin resistance through the immune modulation of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0375-Y

Implication of inflammatory signaling pathways in obesity-induced insulin resistance

21 January 2018

1 reference

12 December 2020

Invited comment on W. Ebstein: On the therapy of diabetes mellitus, in particular on the application of sodium salicylate

1 reference

12 December 2020

Adipocyte death, adipose tissue remodeling, and obesity complications

1 reference

12 December 2020

Multiple risk factor interventions and inflammatory biomarkers in high risk individuals with type 2 diabetes

1 reference

12 December 2020

C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase

1 reference

12 December 2020

Interrelationship between diabetes and periodontitis: a review

1 reference

12 December 2020

Fibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies.

1 reference

12 December 2020

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

1 reference

12 December 2020

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

1 reference

12 December 2020

On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate

1 reference

12 December 2020

Role of vitamin D in insulin resistance

1 reference

12 December 2020

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

1 reference

12 December 2020

A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.

1 reference

12 December 2020

10.1007/S11892-013-0375-Y

Identifiers

DOI

1 reference

PubMed ID

23494755

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23494755